Literature DB >> 12949801

Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors.

Liselotte Dahlgren1, Hanna Mellin, Danny Wangsa, Kerstin Heselmeyer-Haddad, Linda Björnestål, Johan Lindholm, Eva Munck-Wikland, Gert Auer, Thomas Ried, Tina Dalianis.   

Abstract

Our aim was to map and compare genomic imbalances in human papillomavirus (HPV)-positive and -negative squamous cell carcinomas of the tonsil. Twenty-five primary carcinomas were analyzed by comparative genomic hybridization. Fifteen (60%) were found to be HPV-positive by PCR, and the majority were HPV-16. There were statistically significant differences in the distribution of DNA gains and losses between the HPV-positive and -negative samples. Eleven of 15 HPV-positive samples (73%) showed gain on chromosome 3q24-qter, while only 4/10 (40%) HPV-negative samples had the same gain (p = 0.049). Furthermore, 4/10 (40%) HPV-negative samples but no HPV-positive samples had gain on chromosome 7q11.2-q22 (p = 0.017). As expected, and similar to previous studies, patients with an HPV-positive tumor had a statistically significantly better disease-specific survival than patients with an HPV-negative tumor (p = 0.002). The most common changes, e.g., gain on 3q or 8q, loss on 11q or 13 and loss on chromosome 7q in HPV-negative tumors, did not have any influence on prognosis. However the number of cases in each subgroup was limited. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949801     DOI: 10.1002/ijc.11371

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

1.  Molecular characterization of head and neck cancer: how close to personalized targeted therapy?

Authors:  Maria J Worsham; Haythem Ali; Jadranka Dragovic; Vanessa P Schweitzer
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

Review 2.  Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma.

Authors:  Daniel L Miller; Michael D Puricelli; M Sharon Stack
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

3.  Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.

Authors:  Mark Francis Evans; Alisa Matthews; Dina Kandil; Christine Stewart-Crawford Adamson; Winifred Elizabeth Trotman; Kumarasen Cooper
Journal:  Head Neck Pathol       Date:  2011-07-24

4.  Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma.

Authors:  Fangli Cao; Weihong Zhang; Fang Zhang; Hui Han; Junlong Xu; Yufeng Cheng
Journal:  Int J Clin Exp Med       Date:  2014-10-15

5.  High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia.

Authors:  K J Purdie; C A Harwood; K Gibbon; T Chaplin; B D Young; J B Cazier; N Singh; I M Leigh; C M Proby
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

6.  Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells.

Authors:  William C Spanos; Jeremy Geiger; Mary E Anderson; George F Harris; Aaron D Bossler; Russell B Smith; Aloysius J Klingelhutz; John H Lee
Journal:  Head Neck       Date:  2008-02       Impact factor: 3.147

Review 7.  P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects.

Authors:  Hongzhi Wang; Rui Sun; Hui Lin; Wei-Han Hu
Journal:  Cancer Sci       Date:  2013-11-08       Impact factor: 6.716

8.  Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC.

Authors:  Maria J Worsham; Kang Mei Chen; Tamer Ghanem; Josena K Stephen; George Divine
Journal:  Otolaryngol Head Neck Surg       Date:  2013-06-04       Impact factor: 3.497

9.  HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.

Authors:  Efterpi Kostareli; Dana Holzinger; Olga Bogatyrova; Thomas Hielscher; Gunnar Wichmann; Michaela Keck; Bernd Lahrmann; Niels Grabe; Christa Flechtenmacher; Christopher R Schmidt; Tanguy Seiwert; Gerhard Dyckhoff; Andreas Dietz; Daniela Höfler; Michael Pawlita; Axel Benner; Franz X Bosch; Peter Plinkert; Christoph Plass; Dieter Weichenhan; Jochen Hess
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

10.  Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma.

Authors:  Alice Y Chuang; Tony C Chuang; Steven Chang; Shaoyu Zhou; Shahnaz Begum; William H Westra; Patrick K Ha; Wayne M Koch; Joseph A Califano
Journal:  Oral Oncol       Date:  2008-03-07       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.